GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...
People suffering from asthma, performing specific asanas can make a noticeable difference, building resilience without ...
Once state-funded, the centre now faces possible closure after the government withdrew support, saying the treatment lacks ...
Mother's personal story of raising a son with severe asthma highlights the importance of access to Medicaid-covered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results